Shariq Ibrahim, MD
Interventional Pain Medicine · Munster, INNPI 1245336486
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $8,990 of the $9,684 with a category attached, or 92.8%. Globus Medical accounts for 90.7% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $8,826 and has fallen 93.7% since, to $558 in 2025.
Across 22 payments — averaging $440.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Globus Medical$9K
- Stryker$410
- Abbott$307
- Medtronic$83
- Boston Scientific$82
- Relievant Medsystems, Inc.$22
What the payments were for
- Travel & lodging$8,99093%
- Food & beverage$6947%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Globus Medical | 1 | $8,780 |
| Stryker | 5 | $410 |
| Abbott | 8 | $307 |
| Medtronic(2 entities) | 4 | $83 |
| Boston Scientific | 3 | $82 |
| Relievant Medsystems, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,684 in reported general payments places this provider in the 75th percentile of 68 interventional pain medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 96 | $3,765 |
| Gabapentin | 139 | $1,348 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 95 | $1,198 |
| Duloxetine Hcl | 84 | $1,177 |
| Tizanidine Hcl | 62 | $717 |
| Diclofenac Sodium | 13 | $430 |
| Tramadol Hcl | 103 | $412 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 19 | $260 |
| Meloxicam | 40 | $248 |
| Baclofen | 17 | $244 |
| Celecoxib | 14 | $219 |
| Methylprednisolone | 19 | $92 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Munster
- Nikhil ShettyMunster$29K
- Shanu KondamuriMunster$8K
- Prasanth NuthakkiMunster$7K
- Brett BonyngeMunster$6K
- Satish DasariMunster$5K
- Brian McClenicMunster$3K
- Joshua WellingtonCarmel$315K
- Joseph RutledgeLafayette$96K
- Orlando LandrumElkhart$34K
- Mahendra SanapatiEvansville$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.